김승철 교수
Dr. Kim Seung Cheol해당 정보의 수정이나 변경을 희망하는 경우 sungyesacom@gmail.com 문의 부탁드립니다.
학력
1982 | 서울대학교 의과대학 졸업
경력
2015-2017 | 이화여자대학교 의무부총장 겸 의료원장
2013-2018 | 이대여성암정복 특성화연구센터장
2012-2013 | 이화융합의학연구원장
2011-2015 | 이대여성암병원 부인종양센터장
2009-2011 | 이대목동병원장 겸 이대여성암병원장
2009-2011 | 이대여성암병원 초대 원장
2007-2009 | 이대목동병원 의무부장
2002-2008 | 이대목동병원 산부인과 과장
2002-현재 | 이화여자대학교 의과대학 산부인과학 교실 정교수
2000-2001 | 미국, UIHC(University of Iowa Hospitals and Clinics) 부인암 연구소: Research Fellow
1997-2002 | 이화여자대학교 의과대학 산부인과학 교실 부교수
1996-1998 | 이화여자대학교 의과대학 교학부장 역임
1996 | 캐나다, Ontario Cancer Center/Toronto-Sunnybrook Regional Cancer Center 방문교수
1993-1997 | 이화여자대학교 의과대학 산부인과학 교실 조교수
1991-1993 | 충북대학교 의과대학 산부인과학 교실 조교수
1990-1991 | 의료법인 삼성제일병원 산부인과 과장
1986-1990 | 서울대학교 의과대학 산부인과 레지던트
1982-1983 | 서울대학교 병원 인턴
학회
2018-현재 | 대한부인종양학회 회장
2017-2019 | 대한산부인과학회 이사장
2017-2019 | 아시아부인암학회 2019 학술대회 조직위원장 Organizing Committe Chair, ASGO 2019 Biennial Meeting
2016-현재 | 대한암학회 이사
대한산부인과학회 우수논문상 수상
일본산부인과학회 회장상(국제부문) 수상
대한비뇨산부인과학회 우수논문상 수상
대한부인종양.콜포스코피학회 자궁경부암 예방 TFT 위원 역임
대한산부인과학회 정회원, 학술위원, 편집위원
KGOG(한국부인암연구회) 확대 운영위원회 위원
심평원 비상근 위원 역임
대한민국 질병관리본부 예방접종 심의위원회 위원 역임
한국 써비코그래피 연구회 사무총장 역임
한국 써비코그래피 연구회 사무총장 역임
이대목동병원 IRB위원장 역임
2008 AOGIN 행사위원장 역임
Journal of Women's Health, Editorial Member
Journal of Gynecologic Cancer, Editorial Member
세계부인암학회(IGCS: International Gynecological Cancer Society) 정회원
미국 자궁경부병리.콜포스코피 학회(ASCCP: American Society of Colposcopy and Cervical Pathology) 정회원
유럽 부인종양학회(ESGO: European Society of Gynecologic Oncology) 정회원
논문
Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer.. Diagn Cytopathol..
Use of protein-based biomarkers of exfoliated cervical cells for primary screening of cervical cancer.. Arch Pharm Res. .
Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer.. Cancer Res Treat..
Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervica cancer.. Cancer Med. .
Thiol-reducing agents prevent sulforaphane-induced growth inhibition in ovarian cancer cell line.. Food and Nutrition research.
Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer. . Diagnostic cytopathology .
Profiling of serum metabolite using MALDI-TOF mass spectrometry to develope a screen for ovarian cancer. . Cancer Research and Treatment..
Two step chromatograhic purification of gluthathione S –transferase-tagged human papillomavirus type 16 E6 protein and its application for serology. . Protein Expression and Purification .
Subcellularlocalization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells.. Oncotarget .
Anti-Proliferative and Pro-Apoptotic Activities of 4-Methyl-2,6-bis(1-phenylethyl)phenol in Cancer Cells. . Biomolecules Therapeutics. .
Investigation of early and advanced stages in ovarian cancer using human plasma by differential scanning calorimetry and mass spectometry. . Arch Pham Res. .
Low-mass-ion discriminant equation(LOME) for ovarian cancer screening. . BioData Mining.
Increased sialylation and reuced fucosylation of exfoliated cervical cells are potential markers of carcinogenesis in the cervix. . Clin Chem Lab Med .
Association of plasma adiponectin and leptin levels with the development and progression of ovarian. . Obstet Gynecol Sci.
Development and validation of novel digitalized cervicography system. . Obstet Gynecol Sci.
Cellular localization of Foxo3a determines synergistic anti-tumor efficacy of both phsophoinositide 3-kinase (PI3K) and autophagy inhibitors in PIK3CA mutant cervical cancer cells. . KSGO.
Age-ralated reduction of antibody response against the human endogenous retrovirus K envelope in women.. Oncotarget.
lectin-based diagnostic system using circulating antibodies to detect cervical intraepithelial neoplasia and cervical cancer. . Gyncobiology .
Total vaginectomy for refractory vaginal intraepithelial neoplasia III of the vaginal vault, . Obstet Gynecol Science .
Anti-inflammatory and antinociceptive activities of anthraquinone-2-carboxylic acid. . Mediators of Inflammation .
Cost Effectiveness of Human Papillomavirus 16/18 Genotyping in Cervical Cancer Screening. . J Health Tech Assess .
Red meat intake and the risk of endometrial cancer: Metaanalysis of observational studies.. WJMJ .
In vitro and in vivo anti-inflammatory activity of Phyllanthusacidus methanolic extract. . Journal of Ethnopharmacology .
PDK1 disruptors and modulators: A patent review. . Expert Opi. Ther. Patents .
Decreased Cellular Levels of Palmitic Amide are Linked to 5-fluorouracil Resistance in Human Colon Cancer Cells. . Hepatogastroenterology.
AP-1-Targeting Anti-Inflammatory Activity of the Methanolic Extract of Persicaria chinensis. . Evidence-based complementary and alternative medicine. .
Unusual Expression of Thyroid transcription factor-1 and Napsin A in Metastatic Adenoid Cystic Carcinoma of Extrapulmonary Origin in the Lung. . AJCP.
Expression of phosphoenolpyruvate carboxykinase linked to chemoradiation susceptibility of human colon cancer cells. . BMC Cancer .
Functional roles of p38 mitogen activated protein kinase in macrophage-mediated inflammatory responses. . Meditators of Inflammation .
Differential levels of L‑homocysteic acid and lysophosphatidylcholine (16:0) in sera of patients with ovarian cancer.. Oncology Letters .
(5-hydroxy-4-oxo-4H-pyran-2-yl)methyl 6-hydroxynaphthalene-2-carboxylate inhibits NO and PGE2 production via suppression of Syk/Src and NF-kB activation. . International Immunopharmacology .
참고
2014 제100차 대한산부인과학회 추계학술대회 우수논문상